Rise Life Science Corp (RLSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2020 | 11-2019 | 11-2018 | 11-2017 | 11-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 70 | 53 | 303 | 43 | 20 |
| Accounts receivable | -25 | 363 | -250 | -117 | -31 |
| Accounts payable and accrued liabilities | N/A | N/A | 817 | N/A | N/A |
| Other Working Capital | 750 | -1,722 | 182 | -288 | 281 |
| Other Operating Activity | -1,003 | -5,801 | -5,028 | -1,674 | -621 |
| Operating Cash Flow | $-207 | $-7,107 | $-3,976 | $-2,036 | $-351 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -68 | -24 | -15 | 0 |
| Net Acquisitions | N/A | 0 | 167 | N/A | N/A |
| Purchase Sale Intangibles | N/A | 0 | -688 | -213 | 0 |
| Investing Cash Flow | $0 | $-68 | $-544 | $-228 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 40 | 3,686 | 3,734 | 0 | 175 |
| Debt Repayment | -1,943 | -134 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 0 | 3,514 | N/A | 307 |
| Other Financing Activity | 1,925 | 0 | 75 | 3,197 | 0 |
| Financing Cash Flow | $22 | $3,552 | $7,323 | $3,197 | $482 |
| Exchange Rate Effect | 0 | 0 | 9 | N/A | N/A |
| Beginning Cash Position | 254 | 3,878 | 1,066 | 133 | 2 |
| End Cash Position | 69 | 254 | 3,878 | 1,066 | 133 |
| Net Cash Flow | $-185 | $-3,624 | $2,803 | $933 | $131 |
| Free Cash Flow | |||||
| Operating Cash Flow | -207 | -7,107 | -3,976 | -2,036 | -351 |
| Capital Expenditure | N/A | -68 | -712 | -228 | N/A |
| Free Cash Flow | -207 | -7,176 | -4,688 | -2,264 | -351 |